Polyploid giant cancer cells: Unrecognized actuators of tumorigenesis, metastasis, and resistance
Citations Over TimeTop 1% of 2019 papers
Abstract
Cancer led to the deaths of more than 9 million people worldwide in 2018, and most of these deaths were due to metastatic tumor burden. While in most cases, we still do not know why cancer is lethal, we know that a total tumor burden of 1 kg-equivalent to one trillion cells-is not compatible with life. While localized disease is curable through surgical removal or radiation, once cancer has spread, it is largely incurable. The inability to cure metastatic cancer lies, at least in part, to the fact that cancer is resistant to all known compounds and anticancer drugs. The source of this resistance remains undefined. In fact, the vast majority of metastatic cancers are resistant to all currently available anticancer therapies, including chemotherapy, hormone therapy, immunotherapy, and systemic radiation. Thus, despite decades-even centuries-of research, metastatic cancer remains lethal and incurable. We present historical and contemporary evidence that the key actuators of this process-of tumorigenesis, metastasis, and therapy resistance-are polyploid giant cancer cells.
Related Papers
- → Metastasis suppressors Nm23H1 and Nm23H2 differentially regulate neoplastic transformation and tumorigenesis(2015)19 cited
- → Determinants of variability in waiting times for radiotherapy in the treatment of breast cancer(2010)19 cited
- → Tumorigenesis and cell evolution(1995)
- STUDY ON THE EFFECTS OF RADIOTHERAPY ON T-CELL SUBGROUPS OF THE MALIGNANT TUMOR PATIENTS(2000)
- → Progress of the relationship between aberrant p53 protein and tumorigenesis(2019)